1. Opportunities and challenges for the development of covalent chemical immunomodulators
- Author
-
Sean M. Maddox, Jian Cao, and Keriann M. Backus
- Subjects
Cell signaling ,Proteases ,Clinical Biochemistry ,Druggability ,Pharmaceutical Science ,Computational biology ,01 natural sciences ,Biochemistry ,Immune system ,Drug Discovery ,Humans ,Immunologic Factors ,Chemoproteomics ,Cysteine ,Enzyme Inhibitors ,Molecular Biology ,Molecular Structure ,010405 organic chemistry ,Chemistry ,Kinase ,Phosphotransferases ,Organic Chemistry ,Phosphoric Monoester Hydrolases ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Covalent bond ,Molecular Medicine ,Cell signaling pathways ,Peptide Hydrolases ,Signal Transduction - Abstract
Compounds that react irreversibly with cysteines have reemerged as potent and selective tools for altering protein function, serving as chemical probes and even clinically approved drugs. The exquisite sensitivity of human immune cell signaling pathways to oxidative stress indicates the likely, yet still underexploited, general utility of covalent probes for selective chemical immunomodulation. Here, we provide an overview of immunomodulatory cysteines, including identification of electrophilic compounds available to label these residues. We focus our discussion on three protein classes essential for cell signaling, which span the 'druggability' spectrum from amenable to chemical probes (kinases), somewhat druggable (proteases), to inaccessible (phosphatases). Using existing inhibitors as a guide, we identify general strategies to guide the development of covalent probes for selected undruggable classes of proteins and propose the application of such compounds to alter immune cell functions.
- Published
- 2019
- Full Text
- View/download PDF